Antiola, Kyrie Margo .

HRN: 14-56-82  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/14/2023
CEFUROXIME 750MG (VIAL)
11/14/2023
11/21/2023
IV
450 Mg
Q8
PCAP C, BA IN AE
Waiting Final Action 

Indication:  Empiric    Type of Infection:  Pneumonia    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: